Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.
Gu C, Wang Y, Zhang L, Qiao L, Sun S, Shao M, Tang X, Ding P, Tang C, Cao Y, Zhou Y, Guo M, Wei R, Li N, Xiao Y, Duan J, Yang Y.
Gu C, et al. Among authors: duan j.
J Exp Clin Cancer Res. 2023 Apr 19;42(1):91. doi: 10.1186/s13046-023-02672-7.
J Exp Clin Cancer Res. 2023.
PMID: 37072818
Free PMC article.
No abstract available.